Aster Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.25K Sell
49
-239
-83% -$11.9K ﹤0.01% 895
2026
Q2
$13.6K Buy
+288
New +$14.8K ﹤0.01% 641
2025
Q3
– Sell
-135
Closed -$10.8K – 1268
2025
Q2
$10.8K Sell
135
-385
-74% -$32.2K ﹤0.01% 782
2025
Q1
$44.1K Buy
520
+288
+124% +$23.6K 0.01% 849
2024
Q4
$18.1K Buy
+232
New +$18K 0.01% 653

Other funds holding PBH

Aster Capital Management's PBH Position: Q3 2026 in Review

Aster Capital Management reduced its Prestige Consumer Healthcare (PBH) stake by 83% in Q3 2026, selling an estimated $11.9K and leaving 49 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Aster Capital Management first reported a position in PBH in Q4 2024 and has held it in 5 quarters since. The position peaked at $44.1K in Q1 2025. 266 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Aster Capital Management held 49 shares of Prestige Consumer Healthcare worth $2.25K as of Q3 2026.
  • Aster Capital Management sold 239 Prestige Consumer Healthcare shares in Q3 2026, an estimated $11.9K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #895 holding.
  • Aster Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Prestige Consumer Healthcare position peaked at $44.1K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.